SCHEDULE 13D

Company

Ernexa Therapeutics Inc.

Filed

May 20, 2003

Accession Number

0001010192-03-000041

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →